Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Cerilliant
Accenture
QuintilesIMS
Express Scripts
Daiichi Sankyo
US Army
Boehringer Ingelheim
Cipla

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,178,518

« Back to Dashboard

Which drugs does patent 8,178,518 protect, and when does it expire?

Patent 8,178,518 protects TESTIM and is included in one NDA.

This patent has forty-five patent family members in twenty-nine countries.
Summary for Patent: 8,178,518
Title:Pharmaceutical composition
Abstract: A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening agent; including, for example, a composition in which the cyclic enhancer is a macrocyclic ester or a macrocyclic ketone; the use of the composition to treat a condition, for example, male hypogonadism, in a patient by applying the composition to the membrane of the patient; and a method for making the composition.
Inventor(s): Gyurik; Robert J. (Exeter, NH)
Assignee: FCB I LLC (Wilmington, DE)
Application Number:11/931,809
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,178,518

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,178,518

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,320,968 Pharmaceutical composition ➤ Subscribe
7,608,610 Pharmaceutical composition ➤ Subscribe
7,608,608 Pharmaceutical composition ➤ Subscribe
8,063,029 Pharmaceutical composition ➤ Subscribe
7,608,609 Pharmaceutical composition ➤ Subscribe
7,608,605 Pharmaceutical composition ➤ Subscribe
7,608,606 Pharmaceutical composition ➤ Subscribe
7,608,607 Pharmaceutical composition ➤ Subscribe
7,935,690 Pharmaceutical composition ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,178,518

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 039644 ➤ Subscribe
Argentina 087484 ➤ Subscribe
Austria 371456 ➤ Subscribe
Australia 2003228612 ➤ Subscribe
Brazil 0309390 ➤ Subscribe
Canada 2470200 ➤ Subscribe
China 102357098 ➤ Subscribe
China 1662243 ➤ Subscribe
Cyprus 1109005 ➤ Subscribe
Germany 60315939 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Chinese Patent Office
Express Scripts
Cantor Fitzgerald
Fish and Richardson
Julphar
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot